Filing Details

Accession Number:
0000899243-23-006586
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-01 16:16:10
Reporting Period:
2023-02-27
Accepted Time:
2023-03-01 16:16:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590560 Uniqure N.v. QURE Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1867944 Pierre Caloz C/O Uniqure N.v.
Paasheuvelweg 25A
Amsterdam P7 11058BP
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Disposition 2023-02-27 4,284 $19.59 114,206 No 4 S Direct
Ordinary Shares Disposition 2023-02-27 81 $20.80 114,125 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. As required by the relevant Restricted Share Unit Agreement, the Reporting Person sold the Ordinary Shares and remitted the proceeds therefrom to the Issuer to satisfy estimated tax withholding obligations triggered by the vesting of restricted share units.